$INFI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INFINITY PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INFINITY PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INFINITY PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.25 | 7,676 | 9,623 | 599 | 8.3 K to 599 (-92.76 %) |
Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.27 | 42,017 | 53,248 | 8,275 | 50.3 K to 8.3 K (-83.55 %) |
Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.30 | 298 | 387 | 50,292 | 50.6 K to 50.3 K (-0.59 %) |
Dec 14 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Sell | S | 1.30 | 25,009 | 32,612 | 50,590 | 75.6 K to 50.6 K (-33.08 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 2,916 | 3,470 | 550,470 | 547.6 K to 550.5 K (+0.53 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 18,586 | 22,119 | 1,846,995 | 1.8 M to 1.8 M (+1.02 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 30,998 | 36,891 | 2,869,643 | 2.8 M to 2.9 M (+1.09 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 15,161 | 17,958 | 547,554 | 532.4 K to 547.6 K (+2.85 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 52,457 | 62,135 | 1,828,409 | 1.8 M to 1.8 M (+2.95 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 81,276 | 96,271 | 2,838,645 | 2.8 M to 2.8 M (+2.95 %) |
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | General Counsel | Grant | A | 0.00 | 8,917 | 0 | 8,917 | 0 to 8.9 K |
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Grant | A | 0.00 | 39,039 | 0 | 41,905 | 2.9 K to 41.9 K (+1,362.14 %) |
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Grant | A | 0.00 | 75,000 | 0 | 75,599 | 599 to 75.6 K (+12,520.87 %) |
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Grant | A | 0.00 | 59,150 | 0 | 59,150 | 0 to 59.2 K |
Nov 02 2016 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Grant | A | 0.00 | 85,800 | 0 | 447,411 | 361.6 K to 447.4 K (+23.73 %) |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | Baselga Jose | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.52 | 2,000 | 3,040 | 2,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.52 | 10,000 | 15,200 | 10,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.52 | 4,000 | 6,080 | 4,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.52 | 2,000 | 3,040 | 2,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.52 | 13,157 | 19,999 | 107,091 | 93.9 K to 107.1 K (+14.01 %) |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.52 | 4,000 | 6,080 | 4,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Grant | A | 1.52 | 6,578 | 9,999 | 80,319 | 73.7 K to 80.3 K (+8.92 %) |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 1.52 | 20,000 | 30,400 | 20,000 | |
Jun 21 2016 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Grant | A | 1.52 | 26,315 | 39,999 | 30,384 | 4.1 K to 30.4 K (+646.72 %) |
May 04 2016 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | Principal Accountin ... | Option Exercise | A | 5.87 | 40,000 | 234,800 | 40,000 | |
Jan 08 2016 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Option Exercise | A | 6.71 | 70,000 | 469,700 | 70,000 | |
Jan 08 2016 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Option Exercise | A | 6.71 | 60,000 | 402,600 | 60,000 | |
Jan 08 2016 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 6.71 | 80,000 | 536,800 | 80,000 | |
Jan 08 2016 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Option Exercise | A | 6.71 | 185,000 | 1,241,350 | 185,000 | |
Oct 21 2015 | INFI | INFINITY PHARMACEU ... | Bertrand William C JR | General Counsel | Option Exercise | A | 9.42 | 200,000 | 1,884,000 | 200,000 | |
Sep 03 2015 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Grant | A | 8.60 | 2,034 | 17,492 | 73,741 | 71.7 K to 73.7 K (+2.84 %) |
Sep 03 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 8.60 | 2,034 | 17,492 | 93,934 | 91.9 K to 93.9 K (+2.21 %) |
Sep 03 2015 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Grant | A | 8.60 | 4,069 | 34,993 | 4,069 | 0 to 4.1 K |
Jun 26 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 10.93 | 5,000 | 54,650 | 359,432 | 364.4 K to 359.4 K (-1.37 %) |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.06 | 2,000 | 22,120 | 2,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.06 | 10,000 | 110,600 | 10,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | Baselga Jose | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.06 | 4,000 | 44,240 | 4,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.06 | 2,000 | 22,120 | 2,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 11.06 | 4,000 | 44,240 | 4,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
Jun 16 2015 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 10.97 | 4,737 | 51,965 | 868 | 5.6 K to 868 (-84.51 %) |
May 28 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 12.81 | 10,000 | 128,100 | 364,432 | 374.4 K to 364.4 K (-2.67 %) |
May 15 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 12.18 | 10,000 | 121,800 | 374,432 | 384.4 K to 374.4 K (-2.60 %) |
May 01 2015 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 4,737 | 9,663 | 0 | |
May 01 2015 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 4,737 | 9,663 | 5,605 | 868 to 5.6 K (+545.74 %) |
Apr 15 2015 | INFI | INFINITY PHARMACEU ... | Lam Winston K.C. | General Counsel | Option Exercise | A | 15.27 | 200,000 | 3,054,000 | 200,000 | |
Apr 01 2015 | INFI | INFINITY PHARMACEU ... | KANGO SUJAY | Chief Commercial Of ... | Option Exercise | A | 13.98 | 200,000 | 2,796,000 | 200,000 | |
Mar 17 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 16.00 | 20,000 | 320,000 | 384,432 | 404.4 K to 384.4 K (-4.95 %) |
Mar 09 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 16.50 | 25,000 | 412,500 | 404,432 | 429.4 K to 404.4 K (-5.82 %) |
Feb 02 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Sell | S | 14.83 | 20,000 | 296,536 | 427,535 | 447.5 K to 427.5 K (-4.47 %) |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | President & CEO | Option Exercise | A | 15.74 | 250,000 | 3,935,000 | 250,000 | |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Option Exercise | A | 15.74 | 125,000 | 1,967,500 | 125,000 | |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 15.74 | 85,000 | 1,337,900 | 85,000 | |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 15.74 | 125,000 | 1,967,500 | 125,000 | |
Jan 16 2015 | INFI | INFINITY PHARMACEU ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 15.74 | 85,000 | 1,337,900 | 85,000 | |
Dec 16 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 4,737 | 9,663 | 0 | |
Dec 16 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 16.32 | 4,737 | 77,294 | 0 | 4.7 K to 0 (-100.00 %) |
Dec 16 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 4,737 | 9,663 | 4,737 | 0 to 4.7 K |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 11.85 | 1,000 | 11,850 | 1,000 | |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 11.85 | 7,500 | 88,875 | 7,500 | |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 12.94 | 10,000 | 129,400 | 0 | |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 12.94 | 6,000 | 77,640 | 0 | |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 11.85 | 1,000 | 11,850 | 91,900 | 90.9 K to 91.9 K (+1.10 %) |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 11.85 | 7,500 | 88,875 | 90,900 | 83.4 K to 90.9 K (+8.99 %) |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 12.94 | 10,000 | 129,400 | 83,400 | 73.4 K to 83.4 K (+13.62 %) |
Oct 06 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 12.94 | 6,000 | 77,640 | 73,400 | 67.4 K to 73.4 K (+8.90 %) |
Oct 02 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 13.56 | 112,451 | 1,525,229 | 0 | 112.5 K to 0 (-100.00 %) |
Sep 05 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 2,367 | 4,829 | 0 | |
Sep 05 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 7,105 | 14,494 | 0 | |
Sep 05 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 15.39 | 9,472 | 145,774 | 0 | 9.5 K to 0 (-100.00 %) |
Sep 05 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 2,367 | 4,829 | 9,472 | 7.1 K to 9.5 K (+33.31 %) |
Sep 05 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 7,105 | 14,494 | 7,105 | 0 to 7.1 K |
Jul 02 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 12.87 | 879 | 11,313 | 0 | 879 to 0 (-100.00 %) |
Jul 02 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Grant | A | 10.83 | 879 | 9,520 | 879 | 0 to 879 |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.85 | 2,000 | 23,700 | 2,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 11.85 | 4,000 | 47,400 | 4,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.85 | 2,000 | 23,700 | 2,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.85 | 10,000 | 118,500 | 10,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.85 | 4,000 | 47,400 | 4,000 | |
Jun 19 2014 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 11.85 | 15,000 | 177,750 | 15,000 | |
Mar 10 2014 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 14.29 | 30,000 | 428,700 | 30,000 | |
Mar 10 2014 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | M | 8.87 | 2,500 | 22,175 | 2,500 | |
Mar 10 2014 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Buy | M | 8.87 | 2,500 | 22,175 | 10,000 | 7.5 K to 10 K (+33.33 %) |
Mar 10 2014 | INFI | INFINITY PHARMACEU ... | Baselga Jose | Director | Option Exercise | A | 14.29 | 30,000 | 428,700 | 30,000 | |
Feb 27 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 4,736 | 9,661 | 0 | |
Feb 27 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 15.00 | 4,736 | 71,040 | 0 | 4.7 K to 0 (-100.00 %) |
Feb 27 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 4,736 | 9,661 | 4,736 | 0 to 4.7 K |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | Santabarbara Pedro | Chief Medical Offic ... | Option Exercise | A | 12.91 | 16,600 | 214,306 | 16,600 | |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Option Exercise | A | 12.91 | 32,200 | 415,702 | 32,200 | |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | A | 12.91 | 85,500 | 1,103,805 | 85,500 | |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 12.91 | 56,900 | 734,579 | 56,900 | |
Jan 14 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 12.91 | 32,200 | 415,702 | 32,200 | |
Jan 06 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 13.52 | 753 | 10,181 | 0 | 753 to 0 (-100.00 %) |
Jan 06 2014 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Grant | A | 11.74 | 753 | 8,840 | 753 | 0 to 753 |
Dec 04 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 14.56 | 17,756 | 258,527 | 112,451 | 130.2 K to 112.5 K (-13.64 %) |
Nov 27 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 14.56 | 1,200 | 17,472 | 130,207 | 131.4 K to 130.2 K (-0.91 %) |
Nov 27 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 14.72 | 138,961 | 2,045,506 | 131,407 | 270.4 K to 131.4 K (-51.40 %) |
Nov 27 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 15.40 | 23,703 | 365,026 | 270,368 | 294.1 K to 270.4 K (-8.06 %) |
Sep 30 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 2.04 | 4,736 | 9,661 | 0 | |
Sep 30 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 17.28 | 4,736 | 81,837 | 0 | 4.7 K to 0 (-100.00 %) |
Sep 30 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 2.04 | 4,736 | 9,661 | 4,736 | 0 to 4.7 K |
Sep 13 2013 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Sell | S | 20.50 | 13,076 | 268,096 | 447,535 | 460.6 K to 447.5 K (-2.84 %) |
Sep 13 2013 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Sell | S | 20.81 | 31,924 | 664,390 | 460,611 | 492.5 K to 460.6 K (-6.48 %) |
Jun 21 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | M | 1.72 | 22,103 | 38,017 | 0 | |
Jun 21 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Sell | S | 18.53 | 23,150 | 429,067 | 0 | 23.2 K to 0 (-100.00 %) |
Jun 21 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Buy | M | 1.72 | 22,103 | 38,017 | 23,150 | 1 K to 23.2 K (+2,111.08 %) |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 17.34 | 2,000 | 34,680 | 2,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 17.34 | 10,000 | 173,400 | 10,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 17.34 | 4,000 | 69,360 | 4,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 17.34 | 4,000 | 69,360 | 4,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 13 2013 | INFI | INFINITY PHARMACEU ... | Lynch Thomas J. Jr. | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Jun 12 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 17.34 | 2,000 | 34,680 | 2,000 | |
Jun 12 2013 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 17.34 | 15,000 | 260,100 | 15,000 | |
Apr 16 2013 | INFI | INFINITY PHARMACEU ... | Beacon Co | 10% Owner | Sell | S | 38.40 | 5,708,282 | 219,198,029 | 0 | 5.7 M to 0 (-100.00 %) |
Apr 16 2013 | INFI | INFINITY PHARMACEU ... | Rosebay Medical Co L.P. | 10% Owner | Sell | S | 38.40 | 5,708,283 | 219,198,067 | 0 | 5.7 M to 0 (-100.00 %) |
Mar 07 2013 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | M | 16.80 | 6,250 | 105,000 | 0 | |
Mar 07 2013 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Buy | M | 16.80 | 6,250 | 105,000 | 56,250 | 50 K to 56.3 K (+12.50 %) |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Option Exercise | A | 36.85 | 32,800 | 1,208,680 | 32,800 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 36.85 | 101,780 | 3,750,593 | 101,780 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Option Exercise | A | 36.85 | 14,941 | 550,576 | 14,941 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 36.85 | 65,600 | 2,417,360 | 65,600 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Hamermesh Joshua | VP, Business & Corp ... | Option Exercise | A | 36.85 | 14,940 | 550,539 | 14,940 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | A | 36.85 | 153,835 | 5,668,820 | 153,835 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Tucker Winselow S. Jr. | Vice President, Mar ... | Option Exercise | A | 36.85 | 22,410 | 825,809 | 22,410 | |
Jan 08 2013 | INFI | INFINITY PHARMACEU ... | Santabarbara Pedro | Chief Medical Offic ... | Option Exercise | A | 36.85 | 43,735 | 1,611,635 | 43,735 | |
Dec 18 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | M | 8.87 | 2,500 | 22,175 | 2,500 |